coboralâ„¢

  1. T

    Access Pharmaceuticals Presents CobOral™ Insulin Research At 10th Annual Diabetes Tec

    ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that it will be presenting a poster today at the 10th Annual Diabetes...
Back
Top